Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,130 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200B 1764 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| HR Hi RasmusCompany profile Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families. Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families. | $50M | Strategic minority investmentUndisclosed | Healthtech | United States | Investors | |
| MB Medici BrandsCompany profile Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. | $250M | Series B | Foodtech | United States | Investors | |
| C CapacityCompany profile Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform. Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform. | >$54M | Series ESeries C+ | Enterprise software | United States | Investors | |
| B BQPCompany profile A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems. A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems. | Undisclosed | Strategic investmentUndisclosed | AI | United States | Investors | |
| KA Konko AICompany profile Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. | $6M | FundingUndisclosed | Healthtech | United States | Investors | |
| NM N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
| A ArchiveCompany profile A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. | Undisclosed | Growth investmentGrowth | Media & gaming | United States | Investors | |
| N NewlightCompany profile Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. | $9M | Seed | Climate tech | United States | Investors | |
| TT Typewriter TherapeuticsCompany profile Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. | $56M | Series A | Biotech | United States | Investors | |
| LR Locus RoboticsCompany profile Locus Robotics supplies autonomous mobile robots and LocusONE software to warehouse and distribution operators. Locus Robotics supplies autonomous mobile robots and LocusONE software to warehouse and distribution operators. | $41.6M | Series GSeries C+ | Robotics | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.